-
2024-514630-21-00
4
2022-08-11
HER2 positive (HER2+), Hormone Receptor positive (HR+) Early-stage Bre
-
2023-509345-12-00
5
2022-06-22
Multiple Sclerosis
-
2023-507634-24-00
5
2022-05-20
Improper function of certain messenger materials in the body that cont
-
2024-516039-28-00
6
2021-09-28
Spontaneous Coronary Artery Dissection.
-
2023-507188-21-00
5
2021-04-20
Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder
-
2023-504830-23-00
5
2020-12-16
B-cell Lymphoma
-
2022-502611-10-00
5
2020-11-24
Primary Progressive Multiple Sclerosis (PPMS)
-
2023-505852-23-00
5
2020-11-12
High risk recurrent prostate cancer previously treated with radical pr
-
2023-506467-34-00
5
2020-10-20
Relapsing Multiple Sclerosis (MS)
-
2023-505830-89-00
6
2020-08-05
metastatic castrate resistant prostate cancer (mCRPC)
-
2023-506153-38-00
5
2019-07-11
High-risk localized or locally advanced prostate cancer
-
2024-519288-17-00
4
2019-04-26
High-risk Non-muscle Invasive Bladder Cancer
-
2023-507906-15-00
5
2019-01-30
Relapsing multiple sclerosis (RMS)
-
2024-510967-41-00
5
2018-09-21
Metastatic colorectal cancer
-
2023-507889-89-00
5
2016-02-19
Respiratory tract infection
-
2024-511363-28-00
5
2024-09-24
hidradenitis suppurativa (HS)
-
2024-514149-12-00
5
2024-06-26
Septic Shock
-
2023-503502-37-00
4
2024-01-24
Non segmental vitiligo
-
2023-503333-22-00
5
2024-01-15
Moderate to severe controlled asthma according to Step 4 and Step 5 of
-
2023-504328-25-00
4
2023-12-27
hidradenitis suppurativa
-
2023-504418-30-00
4
2023-10-24
Idiopathic Pulmonary Fibrosis
-
2023-503576-25-00
5
2023-09-22
Severe Hypertriglyceridemia
-
2022-501246-30-00
6
2023-03-08
Insomnia Disorder
-
2024-510729-24-00
6
2022-09-01
Chronic Migrane, Migrane, Medication Overuse Headache